Skip to main content

Update to Spine Preauthorization Process

June 26, 2020

To: Orthopedic Surgeons, Neurosurgeons, Physiatrists, Anesthesiologists, Interventional Radiologists, and Pain Management Specialists

Contracts affected: Commercial and Medicare Advantage

To help streamline the preauthorization process for spine procedures and injections, all of these requests will be submitted directly to our Utilization Management Department beginning October 1, 2020. We will no longer require any requests to be submitted through Palladian Health.

As we centralize these preauthorization requests at BlueCross BlueShield, a completed Elective Surgery Preauthorization form will need to be submitted by fax to our Utilization Management department at the fax number listed on the form. You can call us at 1-800-677-3086 with any questions about preauthorization or the form.

Requests for patients covered by administrative services only (ASO) plans are currently submitted directly to us. To simplify your workflow, all spine-related preauthorization requests, (including those for Commercial and Medicare Advantage patients), will be submitted to our Utilization Management team beginning on October 1.

We also continue to evaluate the need to require preauthorization for certain codes. As we have been doing for the past several years, we will remove codes as we determine that they are no longer appropriate for preauthorization. You can log onto our provider portal and search our Code and Comment tool by code to determine whether a preauthorization request is required.  

If you have any questions about this change in process, please contact Provider Service at 1-800-950-0051 or (716) 884-3461.

Recent Articles

  • Pregnancy During the COVID-19 Pandemic
    For many pregnant women, the COVID-19 pandemic has raised new questions about how to get the care they need while staying healthy. According to the Centers for Disease Control and Prevention (CDC), pregnant women might be at a higher risk for severe illness or hospitalization if they contract COVID-19 and they may need additional support during these unprecedented times. Here, we offer guidance and resources for your pregnant patients.
  • CDE-A Program Helps Diabetic Patients Lower A1C
    Our Certified Diabetes Educator Ambassador (CDE-A) program has helped diabetic patients lower their A1C by one full point. As the COVID-19 pandemic continues to raise challenges for people with chronic conditions, this program helps your BlueCross BlueShield patients manage their diabetes and overall health at no cost to them. Find out how your patients can benefit from this supportive program.
  • Reminder: Ancillary Claims Must Be Approved by Supervising Physician
    To ensure proper processing and avoid denials or rejections, ancillary claims, lab orders, specialty pharmacy prescriptions, and referrals for your BlueCross BlueShield patients must be completed in full by the supervising physician of record.
  • The Impact of COVID-19 on Diabetes in Our Community
    It has been widely reported that people with diabetes are especially vulnerable to serious complications from COVID-19 infection. Our webinar, “The Impact of COVID-19 on Diabetes in Our Community” featured local thought leaders to address this concern and offer diabetes care resources to Western New York providers. Here you can view the recording and learn more.
  • Drug Therapy Guidelines Updates July 2020
    New drug therapy guidelines have been developed with the guidance of our Pharmacy and Therapeutics Committee. These guidelines will be posted by August 1 and will be effective September 1. Five medications will require preauthorization.

Working with Us

Additional Resources

We want to hear from you! Have a topic request for the next Blue Bulletin? Email us

Stay in Touch! Sign up to receive emails for provider news and information